Funds that beat their peers in 2022

Juliet Schooling Latter 19/12/22 in Ideas & insights

2022 has been a difficult year for most asset classes. War in Europe, persistently high inflation and rising interest rates have taken their toll on our investments. Equities, bonds, and property have all fallen in value.

But, as we’ve previously reported, some funds and trusts have defied the odds and returned more than 10% for investors.

And, while other funds may have fallen in value, they have still performed relatively well compared to their peers.

Here, we take a look at the Elite Rated funds and trusts that are top of their sectors or have top decile performance in 2022*.

Best performing Elite Rated funds and trusts in 2022

Six Elite Rated funds and trusts are currently top performers in their sectors in 2022*.

They are Fidelity China Special Situations, Fidelity Special Values, Murray International, Polar Capital Global Healthcare Trust, Polar Capital Global Insurance and The Global Smaller Companies Trust. Three of these have posted positive performance in 2022*.

The City of London Investment Trust is currently second in its sector, Fidelity Global Technology is third and both FSSA Global Emerging Markets Focus and M&G Global Dividend are fourth among their peers*.

A further seven funds are top decile in their sectors – an impressive feat given some of these sectors contain more than 500 funds*.

Top ranking and top decile funds in 2022*

Fund / Trust NameTotal returns in 2022SectorRank
Fidelity China Special Situations-20%IT China/Greater China1/4
Fidelity Global Technology-10.4%IA Technology & Technology Innovations3/30
Fidelity Special Values-6.7%IT UK All Companies1/8
FSSA Global Emerging Markets Focus1.3%IA Global Emerging Markets4/156
JOHCM Global Opportunities6.9%IA Global17/502
JP Morgan US Equity Income8.1%IA North America17/237
Jupiter Asian Income4.2%IA Asia Pacific ex Japan11/122
Jupiter Merlin Balanced-4.4%IA Mixed Investments 40-85% Shares18/209
Jupiter UK Special Situations5.1%IA UK All Companies8/253
Lazard Global Equity Franchise7.2%IA Global14/502
M&G Global Dividend5.4%IA Global Equity Income4/56
Murray International19.2%IT Global Equity Income1/7
Polar Capital Global Healthcare Trust7.7%IT Biotechnology & Healthcare1/7
Polar Capital Global Insurance21.5%IA Financial & Financial Innovation1/15
The City of London Investment Trust8.2%IT UK Equity Income2/22
The Global Smaller Companies Trust-14.4%IT Global Smaller Companies1/5
Waverton European Capital Growth-2%IA Europe ex UK13/147

*Source: FE fundinfo, total returns in sterling, 31 December 2021 to 13 December 2022

This article is provided for information only. The views of the author and any people quoted are their own and do not constitute financial advice. The content is not intended to be a personal recommendation to buy or sell any fund or trust, or to adopt a particular investment strategy. However, the knowledge that professional analysts have analysed a fund or trust in depth before assigning them a rating can be a valuable additional filter for anyone looking to make their own decisions. Past performance is not a reliable guide to future returns. Market and exchange-rate movements may cause the value of investments to go down as well as up. Yields will fluctuate and so income from investments is variable and not guaranteed. You may not get back the amount originally invested. Tax treatment depends of your individual circumstances and may be subject to change in the future. If you are unsure about the suitability of any investment you should seek professional advice. Whilst FundCalibre provides product information, guidance and fund research we cannot know which of these products or funds, if any, are suitable for your particular circumstances and must leave that judgement to you. Before you make any investment decision, make sure you’re comfortable and fully understand the risks. Further information can be found on Elite Rated funds by simply clicking on the name highlighted in the article.

Related content